Box score
Dash Bio, Inc.
Reported $30M sold in a new Form D filed July 14, 2026 (Boston, Massachusetts).
- Biggest raise
- $30M filed Jul 14, 2026
- League
- Bio & Health Other Health Care
- Based in
- Boston, Massachusetts
- Season rank
- #87 of 1,121 in the Bio & Health League; #736 of 10,745 overall (2026)
- Incorporated
- 2024
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-07-14 | New notice | $30M | $30M | SEC |
| 2025-06-26 | New notice | $11M | indefinite | SEC |
| 2024-10-17 | New notice | $6.1M | indefinite | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2041370.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Consano Bio, Inc. | Bio & Health | $34.8M |
| 2 | Axoft, Inc. | Bio & Health | $34.2M |
| 3 | NextPoint Therapeutics, Inc. | Bio & Health | $33.7M |
| 4 | Alloy Therapeutics, Inc. | Bio & Health | $30M |
| 5 | Cue Biopharma, Inc. | Bio & Health | $30M |
| 6 | Lonestar Medicines, Inc. rookie | Bio & Health | $25M |